Product Information
PF-06663195 is a drug candidate that binds to the metabotropic glutamate receptor subtype 5 (mGluR5). It is a potent and selective agonist that has been shown to have nootropic effects in animals. PF-06663195 has been found to bind to the mGluR5 with a high affinity, with an IC50 of 0.07 nM. This drug also has kinetic properties, including binding to the mGluR5 in a patterning manner. The compound is currently undergoing clinical trials for the treatment of Alzheimer's disease and may be useful as an effective dose for radiation therapy as well as other diseases.
Chemical properties
Technical inquiry about: 3D-WPC58522 PF-06663195
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.